Clinical trial

The University of Hong Kong Neurocognitive Disorder Cohort

NCT03275363

Drugs and interventions used in this trial

5 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DIAGNOSTIC_TEST · Unmapped registry intervention Neurocognitive battery Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention MRI Find medicine records · Find other trials using this name

BIOLOGICAL · Unmapped registry intervention Blood tests Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention EEG with event-related potential (ERP) Find medicine records · Find other trials using this name

DIAGNOSTIC_TEST · Unmapped registry intervention Amyloid PET CT Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

The University of Hong Kong Neurocognitive Disorder Cohort

Design: OBSERVATIONAL · Status: UNKNOWN · Phase: Not specified

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusUNKNOWN

Study typeOBSERVATIONAL

Start date2014-09-01

PhaseN/A

Conditions

Neurocognitive Disorderunresolved

Mild Cognitive Impairmentunresolved

Alzheimer Dementiaverified · MONDO: Alzheimer disease

Vascular Dementiaverified · MONDO: vascular dementia

Age-related Cognitive Declineunresolved

Interventions

Neurocognitive batteryDIAGNOSTIC_TEST

MRIDIAGNOSTIC_TEST

Blood testsBIOLOGICAL

EEG with event-related potential (ERP)DIAGNOSTIC_TEST

Amyloid PET CTDIAGNOSTIC_TEST

Sponsors & collaborators

The University of Hong Konglead sponsor

Dementias Platform UKcollaborator

Mapped research locations

Hong KongHong Kong1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03275363 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.